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Abstract 
The short-wavelength infrared region (SWIR; 1000—2000 nm) provides several advantages 
over the visible and near-infrared regions for in vivo imaging. The general lack of 
autofluorescence, low light absorption by blood and tissue, and reduced scattering can render a 
mouse translucent when imaged in the SWIR region. Despite these advantages, the lack of a 
versatile emitter platform has prevented its general adoption by the biomedical research 
community. Here we introduce high-quality SWIR-emitting core/shell quantum dots (QDs) for 
the next generation of in vivo SWIR imaging. Our QDs exhibit a dramatically higher emission 
quantum yield (QY) than previously described SWIR probes, as well as a narrow and size-
tunable emission that allows for multiplexing in the SWIR region. To demonstrate some of its 
capabilities, we used this imaging platform to measure the heartbeat and breathing rates in 
awake and unrestrained mice, as well as to quantify the metabolic turnover rates of lipoproteins 
in several organs simultaneously in real time in mice. Finally, we generate detailed three-
dimensional quantitative flow maps of brain vasculature by intravital microscopy and visualize 
the differences between healthy tissue and a tumor in the brain. In conclusion, SWIR QDs 
enable biological optical imaging with an unprecedented combination of deep penetration, high 
spatial resolution, and fast acquisition speed. 
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Introduction 
In order to understand the molecular and cellular mechanisms involved in physiology and 
disease, biomedical research increasingly aims toward non-invasive imaging with cellular 
resolution in vivo. Fluorescent probes in particular can be detected with very high sensitivity, 
ultimately allowing the resolution and tracking of single labeled biological entities. This enables 
the study of rapid biological processes in greater detail than other imaging modalities, such as 
magnetic resonance imaging (MRI), ultrasound (US) or computed tomography (CT). However, 
when imaging whole organisms several biological obstacles remain which reduce the sensitivity, 
acquisition speed, and spatial resolution of fluorescence imaging. Autofluorescence of tissues or 
cells add a background signal, decreasing the contrast and therefore the sensitivity; absorption 
and scattering of the excitation and emission light by blood and other tissue limits signal 
detection and impacts acquisition speeds; and scattering limits the spatial resolution as a 
function of depth, causing blurring of the acquired image. 
Imaging in the short-wavelength infrared (SWIR; 1000—2000 nm) region addresses all of these 
challenges simultaneously. The minimal autofluorescence of biological tissue in the SWIR 
region leads to increased sensitivity1,2, while the significantly reduced light attenuation from 
scattering and from absorption from blood and other structures enables imaging with high 
spatiotemporal resolution and penetration depth2–8. Consequently, large organisms like a whole 
mouse may be rendered translucent when imaged using SWIR fluorescence3,7,9. 
Thus far, the lack of a versatile SWIR emitter technology has prevented the general adoption of 
SWIR in vivo imaging despite its advantages over visible and near-IR imaging. Versatile probes 
ideally need to combine a high fluorescence quantum yield (QY) for sensitive and fast imaging, 
a tunable and narrow emission to generate different colors for multiplexing, and appropriate 
functionalization for specific biological applications. 
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Here we introduce SWIR-emitting InAs-based quantum dots (QDs) as versatile probes for 
biological imaging. These QDs exhibit a dramatically higher QY and stability than previously 
described SWIR probes1,2,7,8,10–16, as well as a narrow and size-tunable emission spectrum 
comparable to established visible-light emitting QDs17. To demonstrate some of the capabilities 
of this imaging platform, we use color-multiplexed imaging to simultaneously detect perfusion 
and uptake of functionalized QDs in the same mouse. We directly quantify metabolic processes 
in real time using QD-labelled lipoproteins, by non-invasively imaging their transition between 
brown adipose tissue (BAT), blood and liver. We use long-circulating PEGylated QDs to assess 
and quantify heartrate and respiration of both sedated and awake mice. We perform 
angiography in the brain of a mouse, directly identifying arteries and veins. We use QD 
composite particles to visualize the dramatic differences between flow of blood in healthy 
vasculature and in vessels at the tumor margin. We finally exploit our ability to track individual 
QD composite particles to quantify blood flow in the vasculature of the brain, with sufficient 
spatial resolution to measure flow in individual capillaries. 
Results 
Characterization of the core/shell QDs 
The emission of core/shell QDs in the SWIR band is size-tunable, with the InAs/CdSe/ZnSe 
QDs (figure 1a) in this work covering the 1050—1400 nm spectral range. Our InAs/CdSe and 
InAs/CdSe/ZnSe QDs (supplementary figures 1 and 2) typically had QYs of 10—20% in 
physiological saline solution, stable over several months (supplementary figure 3), and our best 
sample had a QY of 30%. These QYs are more than one hundred times higher than those of 
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carbon nanotubes (CNTs; 0.1%) and roughly ten times higher than the best performing SWIR 
emitting materials previously applied to biological imaging7,8,10,12–16,18 (figure 1b).A 
Tunable emission allows for the generation of multiple colors in the SWIR band (figure 1c and 
1d, and supplementary video 1). There is little change in the emission spectra and the QYs 
remain high after transfer of the QDs from the organic phase, they were synthesized in, into 
buffer, achieved here by incorporating the QDs into PEG2000-phospholipids micelles 
(figure 1e)19,20. 
In addition to high QY, short photoluminescence lifetimes are important for high-flux applications 
such as confocal microscopy, because the lifetime sets both the maximum excitation flux before 
saturation is reached and the limit on overall emission output. For our samples of InAs QDs, we 
measured photoluminescence lifetimes on the order of 100 ns (supplementary figures 4 and 5), 
which is about one order of magnitude faster than comparable Pb-based QDs.. 
Color SWIR imaging 
The size-tunable emission was used for spectral SWIR imaging in vivo, generating a two-color 
SWIR image of a nude mouse injected with QDs through different administration routes, e.g. 
intraperitoneal (i.p.) application of “green” SWIR QDs and intravenous (i.v.) application of “red” 
SWIR QDs (figure 1f). The i.p. injected “green” SWIR QDs showed a signal pattern consistent 
with a distribution throughout the peritoneal cavity, while the i.v. injected “red” SWIR QDs 
labelled all tissues. 
The emission spectra were narrow and distinct enough to be separated by the use of edge-pass 
filters (figure 2a), without the need for linear unmixing. In vivo, we used differently functionalized 
                                               
A 
 We used an integrating sphere for our QY measurements and our measured QY for CNTs is 
lower than that found in previous reports, which used the dye IR-26 as a QY reference. These earlier 
values rely on a reported QY for the dye IR-26 which has since been found to be ten times too large
47,48
.. 
We have confirmed this corrected value (0.05%) in our lab.  
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SWIR QDs that were administered by intravenous injection and exhibited different 
pharmacokinetics and biodistribution due to different biofunctionalization (figures 2b—h). A 
“green” SWIR QD (QD1080) was embedded in a lipid emulsion of large lipid droplets, which 
after the injection were found in the lungs and organs of the reticulo-endothelial system (RES) – 
mainly in the liver and spleen (figure 2b and 2f). The second sample of “red” SWIR QDs 
(QD1280) was incorporated into micelles formed out of PEG2000-phospholipids19, which are 
roughly 25 nm in hydrodynamic diameter and are known to exhibit a long circulation time20,21. 
These “red” SWIR QDs stay in the blood after injection and all perfused organs show a signal in 
the red channel (figure 2c and 2g). The two channels can be merged (figure 2d and 2h) and a 
reflected light image can also be added for reference (figure 2e), generating a multiplexed color 
SWIR image. 
Metabolic Imaging with functionalized SWIR-QDs 
We and others have recently incorporated visible light-emitting QDs into lipoproteins to follow 
their physiologic fate in vivo22–26. Lipoproteins, in particular triglyceride-rich lipoproteins such as 
chylomicrons, which are micron size micelles, carry dietary lipids absorbed by the intestine 
through the lymphatic system into the blood stream and deliver their cargo to peripheral tissues 
such as brown and white adipose tissue, skeletal muscle and the heart. Similar to glucose, 
triglyceride-rich lipoproteins are a major source of energy for tissues. Therefore SWIR-QD 
labelled lipoproteins should allow studying metabolic activity complementary to 
flurodeoxyglucose (18F) glucose positron emission tomography (FDG PET) imaging.  
Existing methods such as MRI or radioactive labelling are limited by either their sensitivity and 
dynamic range or temporal resolution and invasive nature. The relative transparence of tissues 
at SWIR wavelengths enables tracking of labeled lipoproteins as they circulate and bind to the 
vasculature of target organs. Additionally, the relative lack of autofluorescence from these 
tissues enables the detection of low lipoprotein concentrations, and thus allows for quantification 
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within a large dynamic range. Brown adipose tissue (BAT) is a heat-producing organ, which in 
response to cold exposure fuels its high metabolic activity by the uptake of triglyceride-rich 
lipoproteins. To characterize this process, we exposed wild type mice (4 biological replicates) to 
4°C for 24 hours to activate its BAT. After sedation and preparation, individual mice were 
illuminated with an 808 nm source (15 mW/cm2), and were injected with SWIR QD-labeled 
recombinant chylomicrons via the tail vein at a constant rate of 26.7 μL/min for 9.3 minutes 
(0.267 mg triglycerides/min; figure 3a and supplementary video 2). During and after the injection 
we imaged the SWIR emission. After the experiment, we particularly analyzed the emission 
intensity arising from BAT, peripheral vasculature, and tail vein (figure 3b). The emission 
intensity in each region of interest provided a measure of the relative concentration of the 
labeled chylomicrons at that location, and halting the injection enabled capturing the kinetics of 
the physiological processes at play metabolizing these particles in each organ. This imaging 
paradigm was robust and technically highly reproducible as the variation between four separate 
mice was largely determined only by biological variation between mice (supplementary figure 6), 
and in figure 3b we overlay the results to show the reproducibility and biological variation 
between individual mice. 
From these kinetic traces we were able to measure the blood half-life and rate at which 
chylomicrons are released from the BAT as chylomicron remnants. After the injection into the 
tail was halted the particles cleared from the blood and the signal decay for peripheral 
vasculature is fit well by a sum of two exponential functions and a constant. The blood half-life 
was on the order of 1 minute (73 s +/- 1 s; 42 s +/- 1 s; 70 s +/- 3 s; 58 s +/- 3 s) which is in 
agreement with previously reported values for cold exposed mice based on radioactive 
labeling23. The signal from the BAT decayed significantly slower and is fit well by a sum of two 
exponential functions. The signal remaining in the BAT revealed that initial release of 
chylomicrons remnants, the product of lipolysis, from this tissue occurs with a time constant of 
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about 3 minutes (196 s +/- 5 s; 83 s +/- 1 s; 195.5 s +/- 0.5 s; 241.0 s +/- 0.5 s; roughly half of 
the bound chylomicron population was cleared in this way). This is followed by a much slower 
decay on a time scale of greater than 30 minutes (roughly half of the bound chylomicron 
population showed this behavior). The long residence time is consistent with recent reports 
noting the existence of long-term uptake of particles23. The particles released from the BAT and 
other peripheral tissues got cleared by the liver. 
The SWIR region thus offers three benefits: First, the longer penetration length allows us to 
resolve the image of organs deep in a mouse; Second, as tissues are translucent in this region, 
small concentrations of SWIR QDs can be detected with high temporal resolution even with a 
relatively low excitation flux; and, finally, the relative absence of tissue autofluorescence 
enables the detection of low concentrations and thus allows quantification over a large dynamic 
range (supplementary figure 7). 
High-speed SWIR whole body imaging 
The high QY of our QDs, coupled with the fact that tissues are translucent in the SWIR, gives 
rise to high emission signals even under low excitation fluxes. This allows us to image at 
acquisition speeds of up to 66.5 frames per second (fps) — limited not by signal but by the 
readout electronics of our camera — while retaining high resolution. We achieved an acquisition 
speed more than twice as fast and a resolution with four times more pixels compared to 
previous reports for imaging in the SWIR10. Figure 4 and supplementary videos 3—5 show 
whole body imaging of mice, both anesthetized as well as awake and unrestrained, 
demonstrating the high speed and high signal-to-background ratio of our SWIR QDs. Indeed, 
we measured a signal for the heart and liver that is more than two orders of magnitude higher 
than background autofluorescence, and a signal-to-noise ratio for the liver of about 24 dB for 
our 640x512 pixel camera (figure 4b, supplementary videos 3 and 4). Both heartbeat and the 
respiratory cranio-caudal motion of the liver (figure 4b and supplementary video 4) are clearly 
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resolved. This representative anesthetized mouse shows a respiratory rate of 84 breaths per 
minute (figure 4c) and a heart rate of 130 beats per minute (figure 4d). 
Physiology however, is profoundly affected by anesthesia. Currently used approaches to record 
the heart rate in awake animals rely either on implanting telemetric sensors by surgery or by 
ECG after confining the animal in a device with conductive pads for recording. The emission of 
SWIR QDs signal can overcome this limitation and is in fact strong enough to study freely 
moving and awake mice, in contrast to stationary and anesthetized mice which are required for 
most other imaging techniques such as MRI, CT and US. We injected long-circulating 
PEGylated SWIR-QDs via the tail vein into awake mice and placed them into our imaging setup. 
After allowing the mice to acclimate, we imaged in the dark, reflecting their usual environment 
as a nocturnal species. Notably, the 808nm laser used in this experiment is invisible to mice, as 
their eyes are even less sensitive than humans to these wavelengths27. Figure 4e 
(supplementary video 5) demonstrates our ability to measure the heart and respiratory rates of a 
mouse, in a contact-free way and without restraining or otherwise affecting the mouse. The 
recorded heart and respiratory rates at rest of this representative mouse were 300 breaths per 
minute (figure 4f) and 550 beats per minute (figure 4g), in agreement with the literature28,29 
(SWIR-QD whole body imaging was performed for more than 10 mice). 
In vivo imaging in the SWIR using high-QY QDs thus opens up the possibility of contact-free 
non-invasive physiological imaging of mice that are awake and undisturbed. 
One-photon excitation SWIR intravital microscopy 
The SWIR region of the optical spectrum is also optimal for intravital microscopy. The SWIR 
region benefits from long wavelength excitation in the near-infrared (NIR) similar to multi-photon 
microscopy, allowing deep tissue penetration and relatively high excitation flux without tissue 
damage. But there is one important difference: Multi-photon microscopy relies on two or three 
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photons combining to create a non-linear excitation event in a fluorophore that then emits in the 
visible range. This process is seven to eight orders of magnitude less efficient than emission 
from single photon excitation. The ability to excite in the near-IR with a one-photon event and 
detect in the SWIR gives rise to bright emission at moderate excitation intensities (on the order 
of 10 W/cm2 in our set-up). In comparison, the peak intensity in the focus of multi-photon 
microscopes is on the order of 106–1012 W/cm2. Additionally we benefit from the virtual absence 
of tissue autofluorescence and the high transmission of the SWIR emission. This combination 
allows us to easily generate microscopic images at video rate at penetration depths similar to 
multi-photon microscopy with an epifluorescence approach. 
We used these benefits of SWIR imaging with QDs to image a glioblastoma (GBM) tumor 
growing in a mouse brain through a transparent cranial window (figure 5a). In this experiment 
the tumor was pre-labeled by injection of the PEGylated SWIR-QD composite particles three 
days before imaging. Following relabeling, the tumor continued to grow for the duration of three 
days, and the long-circulating PEGylated SWIR-QD composite particles appeared to 
accumulate in the collapsed and abnormal tumor blood vessels (figure 5b). A second dose of 
the PEGylated SWIR-QD composite particles was injected and perfusion was imaged at video-
rate across the entire cranial window (30 fps, supplementary video 6). The time series of images 
was then deconvolved into the pre-labelled tumor (figure 5b), the arterial vessels (figure 5c) and 
the venous vessels (figure 5d), using a form of principal component analysis30. The resulting 
color-coded image (figure 5e) demonstrates how the growing tumor affects the vascular 
network. 
We further demonstrate here that our PEGylated SWIR-QD composite particles allow detailed 
and quantitative imaging of blood flow in relatively large tissue volumes. Quantification of blood 
flow in the brain is of great importance as it serves as a surrogate for metabolic activity (e.g. in 
functional MRI (fMRI)). Aberrant blood flow in diseases ranging from cancer to stroke often 
11  
leads to hypoxia. Current approaches to measure blood flow either lack the spatial resolution to 
resolve individual capillaries (e.g. fMRI) or are too slow to acquire flow information of large 
volumes (e.g. line-scanning multi-photon microscopy31). 
Z-sectioned images of abnormal and normal vasculature in the same mouse (figure 6a) were 
generated by imaging the dynamics of the flow in healthy tissue (supplementary video 7) and in 
the tumor margin of a GBM (supplementary video 8). The GBM tumor margin showed irregular 
blood flow, including oscillatory “pendular” flow, while the healthy tissue in the contralateral brain 
hemisphere showed a normal vessel network with regular blood flow. Calculating the maximum 
projection of all frames visualized the overall structure of the vasculature in the tumor margin 
(figure 6b) and healthy tissue (figure 6c). The details of the vessel structure, however, were 
contaminated by out-of-plane information. Subtracting the average signal of these 600 frames 
from the maximum intensity projection isolated the signal in the focus originating only from 
individual QD-SWIR composite particles (figures 6d and 6e). 
In another approach to enhance the contrast of the focal plane and provide true z-sectioning 
capability, we calculated the sum of the magnitude of the difference of each frame from the 
average, which is sensitive only to fluctuations over time, i.e. the transit of individual composite 
particles. The static z-sectioned images produced in this fashion are comparable to equivalent 
images produced using multiphoton microscopy (MPM). Figures 6f—k directly compare the 
micrographs of the same fields of view of a healthy mouse brain at various depths, using our 
novel z-sectioning approach (figures 6f—h) and conventional MPM (figures 6i—k).  
It is important to note that we also exploited the high spatiotemporal resolution of our data to 
perform particle image velocimetry (PIV)32–35, yielding z-sectioned measurements of the flow of 
blood through the vasculature at 5 μm increments (figure 7 and supplementary video 9). By 
combining static images of the vasculature (figures 7a and 7c, supplementary videos 10 and 11) 
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with their flow information (figures 7b and 7d), we generated a quantitative three-dimensional 
representation of blood flow in the brain (supplementary video 12) for this representative mouse 
(SWIR-QD intravital microscopy with composite particles was repeated for different organs in 
more than ten mice). Each z-section requires 10 sec of experimental time, so that large volumes 
of brain tissue may be mapped in minutes. The high spatial and velocity resolution of our flow 
maps arise directly from our ability to accurately measure the displacement of individual 
particles over time, which is only achievable by the use of bright and compact labels, such as 
those composed of SWIR QDs. 
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Discussion 
SWIR in vivo fluorescence imaging was introduced as a spectral regime rendering living tissue 
translucent. For example it has previously allowed the observation of brain vasculature through 
skin and skull of mice3. However, the lack of a versatile SWIR emitter technology has prevented 
the general adoption of SWIR in vivo imaging despite its advantages over visible and near-IR 
imaging. Here, we demonstrate that using core/shell SWIR QDs as a functionalizable probe with 
high QY allows for biomedical in vivo imaging of both sedated and awake animals. The use of 
our SWIR biofunctional platform yields detailed information about mouse physiology, 
metabolism, and pathologic processes such as tumor vascularization. 
The deep penetration of SWIR emission and the low levels of background enable us to directly 
measure the metabolic activity of different tissues in a mouse, by tracking lipoproteins labelled 
with SWIR QDs. In contrast to existing methods based on radioactive labelling our technique 
allows measuring the kinetics with a precision of a few seconds that exceeds the biological 
variation between mice of the same group (on the order of tens of seconds). With this method it 
is now possible to completely measure, in real-time and with high dynamic range, lipoprotein 
processing for several organs simultaneously in individual mice. We anticipate future work in 
which the individual mechanisms of binding and uptake can be analyzed in greater detail in 
individual animals, possibly reducing the required amount of biological replicates for 
quantification studies. It is also possible to assess the real-time effects of an intervention within 
an individual animal, such that the results are purely reflective of the effects on the individual 
and not biased by differences within the population. This approach is not limited to lipoproteins 
but can be expanded to study the binding kinetics of therapeutic antibodies or other 
biomolecules. 
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The orders-of-magnitude improvement of signal that QDs provide, relative to existing SWIR 
probes, enables imaging physiological processes that are otherwise too fast to be detected by 
common imaging methods such as MRI or near-infrared fluorescence imaging. In this report we 
demonstrate the measurement of the heartbeat and breathing rates of an awake and 
unrestrained mouse, paving the way for automated and unobtrusive monitoring of animals in 
their normal environments. This method could be applied to test drug candidates for cardiac 
arrhythmia, for which SWIR imaging would enable researchers to monitor the animals over time 
without the need to implant telemetric devices. The ability to non-invasively monitor vital signs 
would also be beneficial for studies of exercise and behavior, where it is critical to ensure that 
the animal is in a normal and unstressed state. 
In a microscopic setting the strong signal of our QDs enables the measurement of blood flow in 
the vasculature of the brain. With such a method, it is possible to characterize the flow in large 
volumes of vasculature in only a few minutes of experimental time, for example before and after 
an intervention to study ischemia-reperfusion in stroke. The applications, however, are not 
limited to pathological processes: almost every tissue can switch between a baseline, resting 
state and an activated state of enhanced functional performance (motion of a muscle, lipolysis 
of white adipose tissue, heat production by BAT) with increased perfusion. Similar to functional 
MRI but with much higher spatial and temporal resolution our technique of flow measurement 
may allow quantification and tracking of the activation of certain areas of the brain by detecting 
changes in blood flow in response to external stimuli. 
Central to all of these applications is the ability to appropriately functionalize QDs. Even an 
emitter with superior optical properties is rendered useless if it cannot be tailored for a given 
application. The widespread adoption of SWIR in vivo imaging will only be enabled by the 
further development of a complete functional library akin to that which exists for visible probes. 
While we did not observe toxic effects in mice during our short-term studies we realize that the 
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chemical composition of our SWIR-QDs might prohibit the use in humans. Thus the 
development of heavy metal-free, high quality SWIR emitters will be the next challenge in order 
to bring SWIR imaging into clinical settings. In the meantime, our versatile and compact probes 
open an avenue toward the broader application of SWIR imaging in biomedical research.  
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Methods 
Synthesis of InAs core/shell QDs 
Synthesis of InAs cores 
In a typical procedure, 4 mmol of indium(III) acetate, 14 mmol myristic acid, and 20 mL 1-
octadecene were added to a 50 mL 4-neck round bottom flask. The flask was heated to 110°C 
under vacuum (10 mtorr) for two hours to remove acetic acid and form a solution of indium(III) 
myristate. The indium myristate solution was heated under argon to 295°C. An injection syringe 
containing 0.22 mmol tris(trimethylgermyl)arsine dissolved in 4 mL tri-n-octylphosphine was 
prepared in a nitrogen glovebox and rapidly injected into the indium myristate solution at 295°C. 
After 10 minutes, a syringe containing 0.72 mmol tris(trimethylgermyl)arsine dissolved in 1 mL 
tri-n-octylphosphine and 4 mL 1-octadecene was loaded into a syringe pump and the arsenic 
precursor solution was injected at 4mL/hour at a temperature of 295°C. The QD size was 
monitored during this step by removing aliquots from the solution. When the QDs reached the 
desired size, the precursor injection was stopped and the reaction was removed from heat. 
The QDs were isolated by filtering the growth solution diluted in toluene through a 200nm PTFE 
filter, then adding acetone to cause the QDs to precipitate out of solution and centrifuging. The 
QDs were dissolved in 20mL hexane and stored for overcoating. 
 
Overcoating InAs cores 
InAs/CdSe/ZnSe 
The ZnSe overcoating procedure is adapted from a published method36. 44 nmol of InAs cores 
in hexane were added to 4 mL of 1-octadecene, 3 mL of oleylamine, and 0.5 mL of 0.05 M 
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trioctylphosphine selenide in TOP (TOPSe). The solution was degassed at 100°C under 
vacuum for 40 minutes, 15 mtorr, to remove the hexane, and then heated to 230°C under argon. 
0.47 mL of solutions of 0.05 M cadmium oleate and 0.05 M TOPSe were injected side by side 
using a syringe pump at 1 mL/hr at 230°C. Then 0.6 mL of 0.05 M diethylzinc was added and 
the temperature was raised to 250°C. After 15 minutes, 0.6 mL of 0.05 M TOPSe was added. 
After 15 minutes, 0.75 mL of 0.05 M diethylzinc was added. After 10 minutes, 0.95 mL of 0.04 M 
Se dissolved in ODE was added. After 15 minutes, 1 mL of oleic acid was injected. After 13 
minutes, 0.95 mL of diethylzinc was added. After another 13 minutes, 1.2 mL of 0.04 M ODE-Se 
was added. The temperature was raised to 290°C for 25 minutes and then the reaction mixture 
was cooled. The quantum yield was found to be 30% using an integrating sphere. The PL peak 
was around 1075 nm. 
InAs/CdS 
This procedure is adapted from conditions described for making CdSe/CdS core/shell QDs37. 
90 nmol of InAs cores in hexanes were added to 10 mL of ODE. The solution was degassed 
under vacuum at 100°C to remove the hexane. 8.2 mL of 0.05 M solutions of cadmium oleate 
and sulfur in 1-octadecene were added side by side using a syringe pump at 5 mL/hr at a 
temperature of 230°C. The PL peak was found to be 1150 nm, with a quantum yield of 35% in 
chloroform. 
Synthesis of PbS/CdS core/shell QDs 
PbS is synthesized with lead oleate as a Pb precursor, hexamethyldisilithiane (as known as 
(TMS)2S) as a S precursor, and 1-octadecene as a solvent
38. All the syntheses were performed 
under an inert atmosphere. Lead oleate is prepared using lead acetate trihydrate and oleic acid 
at 120 oC, then the lead precursor is heated to 150 oC under nitrogen before injection of the 
sulphur precursor. After cooling to room temperature, this solution is transferred into a nitrogen-
filled glove box without air exposure. The synthesized PbS QDs are purified three times by 
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adding methanol and 1-butanol until the solution is turbid, followed by centrifugation to 
precipitate the QDs. The supernatant is discarded and the QDs are re-dissolved in hexane. 
PbS/CdS core/shell QDs are prepared by cation-exchange39,40 at 100 oC for 5 min under 
nitrogen using an excess of cadmium oleate. PbS/CdS core/shell QDs are also precipitated with 
ethanol and re-dissolved into hexane three times to purify and remove unreacted precursors.  
Transfer of QDs from organic solvents into aqueous buffers 
Formation of PEG-phospholipid micelles 
QDs were transferred into aqueous buffers using a previously reported procedure19,20. Briefly, 
3 mg (dry weight) QDs were mixed with 25 mg 18:1 PEG2000 PE (1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]) (ammonium salt) (Avanti Polar 
Lipids; Cat.No 880130) in chloroform. After brief sonication for 10 seconds the solvent was 
removed under nitrogen flow and 2 mL isotonic saline or water were added. To completely 
solubilize the QDs the aqueous solution was sonicated with a probe sonicator for 5 min. This 
solution was filtered through a 0.2 μm filter. 
QD-labelled recombinant triglyceride rich lipoproteins 
QD-labelled recombinant triglyceride rich lipoproteins were generated by a previously reported 
procedure22,23. Briefly, physiological lipoprotein extracts from triglyceride rich lipoproteins (TRL) 
were extracted by the method of Folch41. For incorporating the QDs into the recombinant 
lipoproteins, 20 mg of the lipid extract (approximately 80% triglycerides, 10% cholesterol and 
10% phospholipids) were dissolved in chloroform and mixed with 1 mg (dry weight) InAs 
core/shell nanocrystals. The solvent was removed and TRL were formed in 2 mL PBS or 
isotonic saline by sonication with a probe sonicator for 10 minutes. Potential aggregates were 
removed by filtration using a 0.45 μm filter prior to intravenous injection (2 mg lipid per mouse). 
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PEGylated SWIR-QD composite particles 
To obtain composite particles with a long circulation time 8 mg (dry weight) QDs were mixed 
with 5 mg 18:1 PEG2000 PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000]) (ammonium salt) (Avanti Polar Lipids; Cat.No 880130), 80 
mg soy bean oil and 1.4 mg phosphatidylcholine in chloroform. After brief sonification for 10 
seconds the solvent was removed under nitrogen flow and 2 mL isotonic saline were added. To 
form an emulsion of composite particles the aqueous solution was sonicated with a probe 
sonicator for 10 minutes. This solution was filtered through a 0.45 μm filter, yielding a solution of 
particles which were roughly 400 nm in diameter with a broad size distribution. 
See supplementary table 1 for results of characterization of the different functionalizations. 
Optical characterization of QDs 
Photoluminescence quantum yield (QY) 
Quantum yield measurements were obtained using an integrating sphere (Labsphere RTC-060-
SF). The sample was illuminated using a 785nm diode laser with an excitation power of 25mW 
that was chopped at 210 Hz. The output was collected using a calibrated germanium detector 
(Newport: 818-IR) through a Stanford Research Systems lock-in amplifying system. An 800 nm 
colored glass longpass filter was used to block the excitation beam. The sample was placed in a 
PTFE capped quartz cuvette and a solvent blank was used to ensure as uniform of an 
environment inside the integrating sphere as possible. The measured photocurrent was 
adjusted to account for the external quantum efficiency of the detector when calculating the 
quantum yield. Finally, the measured quantum yield was corrected to account for leakage of the 
excitation light and the transmittance of the filter. 
Photoluminescence spectroscopy 
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For samples with emission peaks between 900 nm and 1300 nm, a single-grating spectromter 
(Acton; SpectraPro 300i) was used in conjunction with a liquid nitrogen cooled InGaAs line 
camera (Princeton Instruments; OMA V, 512x1 pixels). Samples were excited with a 532 nm 
diode laser, and emission was collected using a pair of gold-coated off-axis parabolic mirrors. 
Photoluminescence lifetime 
To measure photoluminescence dynamics by time-correlated single-photon counting (TCSPC), 
samples (solutions in glass vials) were excited by a train of 532 nm, 100 ps-duration pulses at a 
repetition rate of 100 kHz generated by a laser diode (PicoQuant; LDH-P-FA-530B). The 
considerable waiting time between pulses (10 μs) ensured that the delayed fluorescence – 
consistent with long-lived ‘trap’ states on the nanocrystals – decayed below the noise floor of 
the detector (<10-3 of the peak signal under these conditions). The pump was attenuated to yield 
roughly 1 nW of average excitation power, with a roughly 20 μm diameter excitation spot at the 
sample. Under these low-fluence excitation conditions, the photoluminescence decay dynamics 
were independent of excitation intensity. Accordingly, we consider bimolecular recombination 
channels to be unimportant. 
The emission from the nanocrystals was collected and imaged onto an InGaAs/InP single-
photon counting avalanche photodiode (Micro Photon Devices; $IR-DH-025-C), fitted with a 
long-pass filter (Chroma Technology Corp.; EP900LP) to suppress the scattered photons from 
the visible pump. The detector was operated asynchronously from the laser source, with a 
2 MHz gate frequency and a 90% duty cycle. Using a PicoQuant PicoHarp and standard 
software, a decay trace histogram was generated by correlating the times of detection events 
with the proximal trigger from the pump laser. The time resolution, judged from the onset of the 
response to unfiltered pump scatter, was ~300 ps. This stemmed primarily from the uncertainty 
in the detector response at the low over-voltages required for low-noise operation. After 
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verifying that no rapid dynamics were observed, 256 ps time bins were used during data 
collection. 
Animal procedures 
Animal model and cell line 
Murine Gl261 cells (Gl261 WT) were originally provided by the Frederick National Laboratory 
(NCI, Frederick, MD). Gl261-GFP-Gluc cell line was generated by transducing Gl261 WT cells 
with a bicistronic lentivirus vector (under the control of the constitutive cytomegalovirus 
promoter) containing both green-fluorescent-protein (GFP) and Gaussian-luciferase (GFP-Gluc) 
genes separated by an internal ribosomal entry site element42, provided by the MGH vector 
core. All cells were grown in serum free conditions using the NeuroCult NS-A proliferation kit 
(Stemcell technologies, Vancouver, Canada) and maintained in a humidified atmosphere of 5% 
CO2 and 95% air at 37°C. Gl261-GFP-Gluc cells were repeatedly tested negative for 
mycoplasma using the Mycoalert Plus Mycoplasma Detection Kit (Lonza) and authenticated 
before use by IDEXX laboratories (North Grafton, MA). 
Approximately 200,000 tumor cells were implanted stereotactically into the left striatum of 8—
10 week old male C57BL/6 mice (Gl261-GFP-Gluc) 2 mm left of the sagittal suture, 0.1 mm 
rostral of the bregma and at 2 mm depth from the brain surface43,44. Intravital images were taken 
through cranial windows. 
Cold exposure to activate brown adipose tissue 
Mice were housed at 22°C with ad libitum access to standard laboratory chow diet. Cold 
exposure (4°C) was performed in single cages for 24 h. We used male 12 weeks old C57BL/6 
(Charles River Laboratory) wild-type mice, which were fasted for the last 4 h before the imaging 
experiment. For in vivo imaging to measure metabolic rates mice were anesthetized and SWIR-
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QD-labeled lipoproteins were injected via a tail vein catheter with a syringe pump (at a rate of 
13.3 μL/min). 
Animal experiments were conducted in accordance with approved institutional protocols of MGH 
and MIT.  
 
SWIR imaging apparatus 
Macroscopic imaging setup 
For macroscopic imaging from above or below, we used two configurations of a single custom-
built setup.  
We coupled a 10 W 808 nm laser (Opto Engine; MLL-N-808) in a 910 μm-core metal-cladded 
multimode fiber (Thorlabs; MHP910L02). The output from the fiber is passed through a ground-
glass plate (Thorlabs; DG20-220-MD) to provide uniform illumination over the working area. The 
excitation flux in this configuration is around 15mW/cm2. The working area is comprised of a 
plate of clear glass affixed atop four 1 in pillars, 6 in off the table for illumination from above or 
12 in off the table for illumination from below. 
We used a 4 in square first-surface silver mirror (Edmund Optics; Part No 84448) to direct the 
emitted light through various filters (Thorlabs, Edmund Optics) to a Princeton Instruments 
Nirvana equipped with various C-mount camera lenses (Navitar). The whole assembly was 
surrounded by a partial enclosure to eliminate excess light while enabling manipulation of the 
field of view during operation. 
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For imaging of the vasculature of the brain through skin and skull we used a custom build setup 
to lenses (Thorlabs AC254-100-C and AC254-75-C) with a 1" silver elliptical mirror (Thorlabs 
PFE10-P01) and different long- and bandpass filters (Thorlabs and Edmund Optics) in between. 
Microscopic imaging setup 
We used a Nikon Ti-E inverted microscope equipped with a Stage UP Kit (Nikon) and a 
backport adaptor. For illumination we used a 808 nm laser diode coupled to a fiber which was 
attached to the backport adaptor. To eliminate laser speckle we used an optune speckle 
remover (Edmund Optics; 88-397). We used a dichroic filter (Thorlabs; DMLP900R) to direct the 
excitation light to the sample and a 1000 nm longpass filter (Thorlabs; FELH1000,) to select the 
emission light. Imaging was done with a 10X (Nikon; CFI Plan Apo Lambda) or a 2X (Nikon; CFI 
Plan Apo Lambda,) objective. The PI Nirvana camera was attached to the sideport of the 
microscope. The camera was cooled to −80°C for imaging, the AD conversion rate was set to 
10 MHz, the gain set to high, with different exposure times resulting in different frame rates. 
Metabolic imaging with functionalized SWIR-QDs 
The mice were prepared as described in this report. For the resulting images we defined regions 
of interest representing the tail injection site, interscapular brown adipose tissue (BAT), and 
liver. The total intensity contained within each region of interest was determined and used to 
produce the time series data. A constant background was removed from each time series, 
based on the intensities of background fluorescence at the beginning of injection. 
To fit the signal from the BAT, we identified the time point when the injection was halted, and 
noted the intensity of the signal from that point to the end of the experiment. We modeled the 
signal as a sum of three exponential functions, two of which had positive amplitude representing 
loss of signal, and a third with negative amplitude representing residual gain of signal due to the 
injection.  
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Fluorescence angiography 
We used our microscopic imaging setup with the 2X objective to image the brain of a mouse 
with a cranial window. We recorded a video (30fps) of the brain during injection of PEGylated 
QDs, three days after a similar injection to pre-label the tumor. Using this video we can perform 
a form of principal component analysis (PCA), using the PoissonNMF ImageJ plugin45. This 
method identifies the extent to which each pixel can be represented as an artery or vein by 
relating its temporal profile to those of vessels of known identity. Any signal existing before the 
imaged injection was assigned to be the background and pre-labeled tumor, from which we 
removed a laser speckle artifact by a form of flat field correction by combining multiple pictures 
taken with different fields of view before the injection. The color image in figure 5e represents 
the overlay of pre-injection, artery, and vein characters. 
Multiphoton microscopy 
Fluorescein isothiocyanate–dextran/phosphate buffered saline solution (FITCDextran) was 
prepared for in vivo vessel tracing in a concentration of 10 mg/mL. Following tail vain injection of 
100 μL of FITC-Dextran, a vessel image was acquired using multiphoton imaging described 
previously43 on a custom-built multiphoton laser-scanning microscope using confocal laser-
scanning microscope body (Optical Analysis Corp.; Olympus 300) and a broadband 
femtosecond laser source (Spectra-Physics; High Performance MaiTai). Image slices were 
taken with 300 mW at a wavelength of 810 nm. Imaging studies were performed with a 20X 
magnification, 0.95NA water immersion objective (Olympus XLUMPlanFl, 1-UB965, Optical 
Analysis). Image analysis was carried out using ImageJ. 
Particle image velocimetry 
The PIV code was written in Matlab 2015a and is available here: 
https://github.com/massivehair/PIV 
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Firstly, the image stack is segmented into two regions, one containing flow and the other, 
background. This is achieved by first smoothing every frame in the stack using a Gaussian 
smoothing kernel with a sigma parameter of 2 pixels. The standard deviation of each X,Y 
position in the stack is taken, as a measure of the amount of motion in that part of the image. 
Finally, a grayscale image erosion operation using a disk kernel with a diameter of 25 pixels is 
used to reduce the influence of noisy pixels and isolated high-variance regions of the image. A 
threshold could then be selected to distinguish flowing regions from background. Since the 
effect of this threshold (and the prior steps) is to reduce the computational load of calculating 
large areas in which there is no flow, the algorithm is not especially sensitive to the choice of 
smoothing kernel, or threshold that is too low; any errors will simply reduce computational 
efficiency. For the data presented in figure 7 a threshold of 0.2 was used. 
To perform the PIV calculation, firstly, each frame is smoothed using a Wiener filter with a filter 
size of 5 pixels on a side. A window size and maximum step size are defined. In the case of the 
data presented in figure 7 the window size is 8 pixel and the step size 40 pixel. Flow is 
calculated at grid locations spaced by the window size, provided these locations contain flow 
information (as assessed by the threshold previously applied). To calculate flow, two sub-
images are taken from consecutive frames. One is taken from the first frame, centered on each 
grid location, with a size given by the window size. The second is taken from the subsequent 
frame, centered on the same grid location, with a size equal to the sum of the window size and 
the maximum step size. A cross-correlation is then taken between the two sub-frames; this is 
termed the correlation map. This is repeated for every grid locations, resulting in n-1 correlation 
maps for each, where n is the number of frames in the stack. 
Correlation maps were averaged across all frames, following the method of Meinhart, Wereley 
and Santiago46, and then the peak corresponding to the modal flow vector located using a three-
point Gaussian estimator47.  
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Figures 
 
Figure 1: InAs core/shell quantum dots with high quantum yield and size-
tunable emission for functional and high-speed SWIR imaging.  
A schematic of core/shell SWIR quantum dots is shown in (a). Core/shell SWIR QDs exhibit a 
quantum yield in aqueous buffer of up to 30%, much higher than for previously-used materials 
(b)Error! Bookmark not defined. Spectra of five different core/shell SWIR QDs are shown (c). 
A spectral image of those five samples yields a pseudo-color SWIR image (d). The emission 
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spectra change only minimally after transfer into aqueous buffer (e). Two different SWIR-QDs 
were injected into a nude mouse intraperitoneally (green) and intravenously (red). A spectral 
image was taken and separated into red and green by linear unmixing (f). 
  
33  
 
 
Figure 2: Color QD-SWIR imaging for multiplexing and functional imaging.  
(a) Two different SWIR QDs, color-coded green and red, were functionalized differently for 
multiplexing. SWIR-QDs in a lipid emulsion (QD1080) and PEGylated SWIR-QDs (QD1280) 
were subsequently injected into a mouse. The mouse was sacrificed and opened prior to color 
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SWIR imaging. The PEGylated SWIR-QDs (QD1280) were excited using an 808 nm laser and 
detected selectively with 1250 nm longpass filter (b) and the SWIR-QDs in a lipid emulsion 
(QD1080) were imaged with the combination of a 850 nm longpass and a 1100 nm shortpass 
filter (c). The overlay of both is shown in (d) and an overlay with an additional reflected light 
picture in grayscale is shown in (e). The organs were excised and the pictures for lipid emulsion 
(QD1080) (f), PEGylated SWIR-QDs (QD1280) (g) and the overlay (h) are shown. 
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Figure 3: SWIR-QDs for functional and metabolic imaging 
(a) A solution of a SWIR QD labeled recombinant chylomicrons was injected at a constant rate 
(26.7 μL/min or 0.267 mg triglycerides/min) into the tail vein of a cold-exposed mouse. The 
mouse was illuminated using an 808 nm laser with 15 mW/cm2, and the SWIR emission was 
measured for the brown adipose tissue (BAT), liver and tail vein. (b) This process was repeated 
for four mice, with the darkened curves representing the results from the one mouse shown in 
(a), and the lighter curves showing the qualitative similarity of the other mice. The BAT signal 
after the injection revealed two distinct timescales for clearance: the initial signal loss is 
consistent with binding and release (about 3 minute time constant, 50% of the signal), while the 
longer-term component is consistent with uptake (>30 minute time constant).
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Figure 4: High-speed QD-SWIR imaging for contact free monitoring of heart 
and respiratory rate in anesthetized and awake mice. 
Imaging in ventral orientation (a) at video-rate (30 fps; supplementary video 4) with SWIR-QDs 
(808 nm excitation) allows imaging vital signs like heart rate (red ROI) and respiration (blue 
ROI). (b) The respiratory rate of this anesthetized mouse is 84 breaths per minute (c) and the 
heart rate is 130 beats per minute (d). The bright emission of our SWIR-QDs allows the imaging 
of an awake mouse (66.5 fps; supplementary video 5) and the detection of the signal 
fluctuations generated by motion of liver and heart (e). A respiratory rate of 300 breaths per 
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minute (f) and a heart rate of 550 beats per minute (g) is observed in this awake but resting 
mouse.  
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Figure 5: High-speed QD-SWIR intravital imaging 
SWIR intravital imaging (808 nm excitation, 1000nm long pass for emission) in a mouse with a 
cranial window (a) bearing a glioblastoma multiforme (GBM) in the left hemisphere of the brain 
as shown in (b). Principal component analysis (PCA) was used to distinguish arterial (c) from 
venous vessels (d) in the brain. This information is color-coded creating a multicolor angiograph 
(e) showing the abnormalities of the tumor microvascular network as opposed to normal 
arterial/venous brain vasculature (green: tumor; red: arterial vessels; blue: venous vessels). 
Scale bars are 1500 μm.  
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Figure 6: High resolution high-speed QD-SWIR intravital imaging.  
In addition to generating a multicolor angiography image of a glioblastoma tumor in a cranial 
window model (a) high-resolution high-speed QD-SWIR imaging at 60 fps was used to image 
the vascular network of the tumor margin (b) and to compare it to the vasculature in the 
contralateral hemisphere (c). Maximum intensity projections of 600 frames over 10 seconds are 
shown here. By subtracting the average signal of these 600 frames from the maximum intensity 
projection the signal originating only from individual QD-SWIR composite particles in the focus 
was isolated. This allowed isolating blood flow from the focal plane of the tumor margin (d) and 
the vessels on the contralateral lateral side (e). To enhance the contrast of the focal plane and 
provide true z-sectioning capability, we calculated the sum of the magnitude of the difference of 
each frame from the average, which is sensitive only to fluctuations over time, i.e. the transit of 
individual composite particles. Figures f—k directly compare the micrographs of the same fields 
of view of a healthy mouse brain at various depths taken by our novel z-sectioning approach 
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(f—i) and conventional multiphoton microscopy (i—k). Scale bars in b—e are 300 μm, and in f—
k are 200 μm. Scale bar for (a) is 1500 μm, scale bars for (b—e) are 300 μm and scale bars for 
(f—k) are 200 μm. 
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Figure 7: High resolution high-speed QD-SWIR intravital imaging to generate 
flowmaps of microvascular networks. 
Applying our novel z-sectioning approach in 5 μm steps in a healthy mouse brain results in a z-
resolved three-dimensional representation of the vascular network. Furthermore the signal from 
the particles in the focus (a and c; the difference from the average signal, maximum intensity 
projection of 600 frames), analyzed by a multi-pass particle image velocimetry (PIV) approach, 
generate a flow map for each slice (b and d, supplementary video 12). All scale bars are 
300 μm, and the units for velocity are μm/s (b and d).  
